|
1. Xiao Zhao, Song Gao, et al. Hypoxia-Inducible Factor-1 Promotes Pancreatic Ductal Adenocarcinoma Invasion and Metastasis by Activating Transcription of the Actin-Bundling Protein Fascin, Cancer Research, 2014, 74(9): 2455-2464
2. Xiao Zhao, Feng Li, et al. Co-delivery of HIF1 alpha siRNA and Gemcitabine via Biocompatible Lipid-polymer Hybrid Nanoparticles for Effective Treatment of Pancreatic Cancer, Biomaterials, 2015, 46: 13-25
3. Jiayan Lang#, Xiao Zhao#*, et al. Targeted Co-delivery of the Iron Chelator Deferoxamine and a HIF1α Inhibitor Impairs Pancreatic Tumor Growth. ACS Nano, 2019, 13:2176-2189 (共同第一作者，共同通讯作者)
4. Xiao Zhao, Xiuchao Wang, et al. Precision Design of Nanomedicines to Restore Gemcitabine Chemosensitivity for Personalized Pancreatic Ductal Adenocarcinoma Treatment. Biomaterials, 2018, 158: 44-55
5. Feng Li#, Xiao Zhao#, et al. Multiple Layer-by-Layer Lipid-Polymer Hybrid Nanoparticles for Improved FOLFIRINOX Chemotherapy in Pancreatic Tumor Models, Advanced Functional Materials, 2015, 25(5): 788-798 (共同第一作者)
6. Xiao Zhao, Liang Liu, et al. A CRISPR-Cas13a System for Efficient and Specific Therapeutic Targeting of Mutant KRAS for Pancreatic Cancer Treatment. Cancer Letters, 2018, 431: 171-181
7. Xiao Zhao, Xiuchao Wang, et al. A Combinatorial Strategy Using YAP and Pan-RAF Inhibitors for Treating KRAS-mutant Pancreatic Cancer. Cancer Letters, 2017, 402: 61-70
8. Xiao Zhao, Keni Yang, et al. Inducing Enhanced Immunogenic Cell Death with Nanocarrier-based Drug Delivery Systems for Pancreatic Cancer, Biomaterials, 2016, 102: 187-197
9. Guangna Liu#, Xiao Zhao#, Yinlong Zhang#, et al. Engineering Biomimetic Platesomes for pH-Responsive Drug Delivery and Enhanced Anti-Tumor Activity. Advanced Materials, 2019 (共同第一作者, In Press)
10. Shaoli Liu#, Yinlong Zhang#, Xiao Zhao#, et al. Tumor-specific Silencing of Tissue Factor Suppresses Metastasis and Prevents Cancer-associated Hypercoagulability. Nano Letters, 2019 (共同第一作者, In Press)
|
